Authors:
Bertho, JM
Demarquay, C
Frick, J
Joubert, C
Arenales, S
Jacquet, N
Sorokine-Durm, I
Chau, Q
Lopez, M
Aigueperse, J
Gorin, NC
Gourmelon, P
Citation: Jm. Bertho et al., Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia, INT J RAD B, 77(6), 2001, pp. 703-712
Authors:
Schlegel, PN
Kuzma, P
Frick, J
Farkas, A
Gomahr, A
Spitz, I
Chertin, B
Mack, D
Jungwirth, A
King, P
Nash, H
Bardin, CW
Moo-Young, A
Citation: Pn. Schlegel et al., Effective long-term androgen suppression in men with prostate cancer usinga hydrogel implant with the GnRH agonist histrelin, UROLOGY, 58(4), 2001, pp. 578-582
Authors:
Hiki, N
Berger, D
Mimura, Y
Frick, J
Dentener, MA
Buurman, WA
Seidelmann, M
Kaminishi, M
Beger, HG
Citation: N. Hiki et al., Release of endotoxin-binding proteins during major elective surgery: Role of soluble CD14 in phagocytic activation, WORLD J SUR, 24(5), 2000, pp. 499-506
Authors:
Bertho, JM
Chapel, A
Loilleux, S
Frick, J
Aigueperse, J
Gorin, NC
Gourmelon, P
Citation: Jm. Bertho et al., CD135 (Flk2/Flt3) expression by human thymocytes delineates a possible role of FLT3-ligand in T-cell precursor proliferation and differentiation, SC J IMMUN, 52(1), 2000, pp. 53-61
Authors:
Bito, M
Czihak, G
Betz, S
Wastian, E
Frick, J
Citation: M. Bito et al., Differences in the DNA-stainability of spermatozoa from fertile and suspected infertile men, INT J ANDR, 22(4), 1999, pp. 275-281